Lan-lan Zhong

Dr. Lan-lan Zhong


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2015 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
SHSheng-Feng Hu
Sheng-Feng Hu
MLMiao Li
Miao Li
LZLan-lan Zhong
Lan-lan Zhong
SLShi-Miao Lu
Shi-Miao Lu
ZLZe-Xia Liu
Ze-Xia Liu
XHXi Huang
Xi Huang
Dengue virus (DENV), the most widely prevalent arbovirus, continues to be a threat to human health in the tropics and subtropics. Early and rapid detection of DENV infection during the acute phase of illness is crucial for proper clinical patient management and preventing the spread of infection. The aim of the current study was to develop a specific, sensitive, and robust reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) assay for detection and differentiation of DENV1-4 serotypes. The method detection primers, which were designed to target the different DENV serotypes, were identified by inspection of multiple sequence alignments of the non-structural protein (NS) 2A of DENV1, NS4B of DENV2, NS4A of DENV3 and the 3′ untranslated region of the NS protein of DENV4. No cross-reactions of the four serotypes were observed during the tests. The detection limits of the DENV1-4-specific RT-LAMP assays were approximately 10-copy templates per reaction. The RT-LAMP assays were ten-fold more sensitive than RT-PCR or real-time PCR. The diagnostic rate was 100 % for clinical strains of DENV, and 98.9 % of the DENV-infected patients whose samples were tested were detected by RT-LAMP. Importantly, no false-positives were detected with the new equipment and methodology that was used to avoid aerosol contamination of the samples. The RT-LAMP method used in our study is specific, sensitive, and suitable for further investigation as a useful alternative to the current methods used for clinical diagnosis of DENV1-4, especially in hospitals and laboratories that lack sophisticated diagnostic systems.

28 April 2022 in Emerging Microbes & Infections
Verified
Journal Article
Open access
SFSiyuan Feng
Siyuan Feng
WLWanfei Liang
Wanfei Liang
JLJiachen Li
Jiachen Li
YCYong Chen
Yong Chen
DZDianrong Zhou
Dianrong Zhou
GTGuo-Bao Tian
Guo-Bao Tian
The global dissemination of the mobilized colistin resistance gene, mcr-1, threatens human health. Recent studies by our group and others have shown that the withdrawal of colistin as a feed additive dramatically reduced the prevalence of mcr-1. Although it is accepted that the rapid reduction in mcr-1 prevalence may have resulted, to some extent, from the toxic effects of MCR-1, the detailed mechanism remains unclear. Here, we found that MCR-1 damaged the outer membrane (OM) permeability in Escherichia coli and Klebsiella pneumonia and that this event was associated with MCR-1-mediated cell shrinkage and death during the stationary phase. Notably, the capacity of MCR-1-expressing cells for recovery from the stationary phase under improved conditions was reduced in a time-dependent manner. We also showed that mutations in the potential lipid-A-binding pocket of MCR-1, but not in the catalytic domain, restored OM permeability and cell viability. During the stationary phase, PbgA, a sensor of periplasmic lipid-A and LpxC production that performed the first step in lipid-A synthesis, was reduced after MCR-1 expression, suggesting that MCR-1 disrupted lipid homeostasis. Consistent with this, the overexpression of LpxC completely reversed the MCR-1-induced OM permeability defect. We propose that MCR-1 causes lipid remodelling that results in an OM permeability defect, thus compromising the viability of Gram-negative bacteria. These findings extended our understanding of the effect of MCR-1 on bacterial physiology and provided a potential strategy for eliminating drug-resistant bacteria.

27 November 2023 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
ZZZihan Zhao
Zihan Zhao
SWShu'AN Wen
Shu'AN Wen
NSNingning Song
Ningning Song
LWLixiang Wang
Lixiang Wang
YZYuan Zhou
Yuan Zhou
LZLan-lan Zhong
Lan-lan Zhong

2 October 2025 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
GZGuili Zhang
Guili Zhang
YZYuan Zhou
Yuan Zhou
BYBin Yan
Bin Yan
CWChangbu Wu
Changbu Wu
YYYanxian Yang
Yanxian Yang
LZLan-lan Zhong
Lan-lan Zhong
Emergence and global expansion of the multidrug-resistant (MDR) clones of Acinetobacter baumannii which often cause difficult-to-treat infections, have been increasingly reported in nosocomial and community-acquired infections. However, as the most widely prevalent sequence type of MDR A. baumannii, the distribution and evolution of ST2 A. baumannii remain obscure. In this study, a multicenter epidemiological survey was conducted using A. baumannii isolates obtained from 27 provinces and municipalities across China between 1999 and 2022. It was observed that ST2 was the most common sequence type among the A. baumannii isolates in China. Subsequently, 143 representative ST2 isolates were selected for genomic and evolutionary analyses. Out of these, 23 isolates were collected in this study, while an additional 120 isolates were downloaded from the GenBank database. We demonstrated that ST2 A. baumannii strains had diverse phylogenetic structures with nine sequence clusters (SCs). Extensive recombination events related to capsular polysaccharides and phages were detected, enabling distinction between different SCs. A high number of antibiotic resistance genes (ARGs) (Median 30 [range 22 to 36]) were identified, with 23 strains in this study showing pandrug resistance. All 143 ST2 strains were found to carry genes associated with antibiotic efflux pumps, such as amvA, adeGH and adeIJK, abeS, and abeM, with a most recent common ancestor (MRCA) arose around 1976. Antimicrobial susceptibility testing (AST) showed that 23 isolates collected in this study were resistant to meropenem. Extensive presence of A. baumannii genomic resistance islands (AbGRIs), including AbGRI1, AbGRI2, and AbGRI3, was observed within ST2 A. baumannii, with multiple resistance genes co-located. This study demonstrated the homologous recombination and antibiotic resistance contribute to evolution of ST2 A. baumannii, with a MRCA arose around 1976 in China. The results are highly relevant for enhancing the understanding of ST2 A. baumannii diversity and evolutionary pathways among practitioners, researchers and policymakers, informing infection reduction strategies.

13 September 2025 in EBioMedicine
Verified
Journal Article
Open access
LLLujie Liang
Lujie Liang
YLYaxin Li
Yaxin Li
LWLin Wang
Lin Wang
WWWenli Wang
Wenli Wang
YZYihao Zhang
Yihao Zhang
GTGuo-Bao Tian
Guo-Bao Tian
The rapid evolution and dissemination of mobilised colistin resistance gene (mcr) family has revealed as a severe threat to the global public health. Nevertheless, dramatic reduction in the prevalence of mcr-1, the major member of mcr family, was observed after the withdrawal of colistin in animal fodder in China since 2017, demonstrating that colistin acts as a selective stress to promote the dissemination of mcr-1. As the second largest lineage, mcr-3 was firstly discovered in 2017 and has been identified from numerous sources. However, whether the spreading of mcr-3 is driven by colistin remains unknown. To this end, we investigated the global prevalence of mcr-3 from 2005 to 2022 by an up-to-date systematic review, along with a nation-wide epidemiological study to establish the change of mcr-3 prevalence in China before and after 2017. To investigate the fitness cost imposed by MCR-3 upon bacterial host, in vitro and in vivo competitive assays were employed, along with morphological study and fluorescent observation. Moreover, by replacing non-optimal codons with optimal codons, synonymous mutations were introduced into the 5'-coding regions of mcr-3 to study mechanisms accounting for the distinct fitness cost conferred by MCR-1 and MCR-3. Furthermore, by combining AlphaFold and molecular dynamics (MD) simulation, we provided a complete characterisation on the putative lipid A binding pocket localised at the linker domain of MCR-3. Crucially, inhibitors targeting at the putative binding pocket of MCR-1 or MCR-3 were identified from small molecules library using the pipeline of virtual screening. The global prevalence of mcr-3 increased continuously from 2005 to 2022. The average prevalence was 0.18% during 2005-2014 and rapidly increased to 3.41% during 2020-2022. The prevalence of mcr-3 in China increased from 0.79% in 2016 to 5.87% in 2019. We found that the fitness of mcr-3-bearing Escherichia coli and empty plasmid control was comparable but higher than that of mcr-1-positive strain. Although the putative lipid A binding pocket of MCR-3 was similar to that of in MCR-1, mcr-3 occupies remarkable codon bias at the 5'-end of coding region that disrupted the stability of mRNA, further reduced its protein expression in E. coli, resulting in the low fitness burden of bacterial host. Moreover, the 5'-end codon usage frequency appeared as a critical factor related with the evolution of mcr family. Furthermore, based on the similar lipid A binding pocket among MCR family protein, we identified three MCR inhibitors targeting at such pocket by screening from small-molecule library, which effectively restored the colistin susceptibility of mcr-bearing E. coli. We found that the prevalence of mcr-3 increased continuously during 2016-2019 in China, demonstrating that the withdrawal of colistin in husbandry failed to prevent the dissemination of mcr-3. Our study evidenced that the 5'-end codon bias appeared as a crucial regulator upon the fitness cost conferred by horizontally transferred genes. Most importantly, the putative lipid A binding pocket verified from current study was a promising target site for designing inhibitors against mcr-positive strains. Natural Science Foundation of China, National Key Research and Development Programme of China.

1 August 2023 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
WHWan He
Wan He
CWChangbu Wu
Changbu Wu
GCGuanping Chen
Guanping Chen
GZGuili Zhang
Guili Zhang
ZZZihan Zhao
Zihan Zhao
MDmin dai
min dai
Background: The emergence and spread of hypervirulent carbapenem-resistant Klebsiella pneumoniae (hv-CRKP) is a potential epidemiological threat that needs to be monitored. However, the transmission and pathogenic characteristics of hv-CRKP in China remain unclear. We investigated the epidemiological characteristics of gut colonized hv-CRKP in a hospital in Guangdong Province, China. Methods: A total of 46 gut colonized hv-CRKP isolates were collected from Sun Yat-Sen Memorial Hospital (Guangzhou, China) from August 31st to December 31st, 2021. Minimum inhibitory concentrations (MICs) were obtained for 15 antibiotics for 46 hv-CRKP isolates. BALB/C mice infection model and mucoviscosity assay was used to evaluate the virulence of the isolates. The characteristics of genome, phylogenetic relationship and the structure of the plasmid of 46 gut colonized hv-CRKP isolates were compared with pathogenic isolates from GeneBank based on whole-genome data. Results: The hv-CRKP isolation rate of all gut colonized carbapenem-resistant Klebsiella pneumoniae was 17% (46/270), and the intestinal colonization rate of hv-CRKP was irrelevant to the sex, age, department of hospitalization, and history of antibiotic use of the host. The gut colonized hv-CRKP showed pandrug resistance and hypervirulence. The gut colonized hv-CRKP and pathogenic hv-CRKP prevalent in China were mainly ST11 hv-CRKP and had two major epidemic clades. The similarities in genomic characteristics between gut colonized hv-CRKP and pathogenic hv-CRKP were consistent. The gut colonized hv-CRKP carried an incomplete structure pK2044 virulence plasmid from hypervirulent K. pneumoniae NTUH-K2044 by analyzing the virulence plasmid structure. Conclusion: Our results suggest that the gut colonized ST11 hv-CRKP may serve as a reservoir for the clinical pathogenic ST11 HV-CRKP. It is necessary to further strengthen the monitoring of gut colonized hv-CRKP and research the potential mechanism of infection caused by gut colonized hv-CRKP.